Published in Blood Weekly, March 27th, 2003
The challenge in measuring heparin activity during CPB is that hemodilution has a remarkably negative impact on traditional measurement methods. In this study, an instrument commonly used today consistently indicated a reduction in heparin concentration after initiation of CPB even though the concentration actually rises because of the heparin that is added to the pump. The study showed that a new instrument, Rapidpoint Coag/Accent, overcomes this problem. ...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.